Institution record
Conotoxia
Conotoxia Ltd
- Source score
- —
- Warnings
- 0
- Comments
- 0
Licence records
Licences within our coverage (institutions licensed across asia-pacific and the middle east) are listed first. Check each one on the regulator's own register.
| Regulator | Licence no. | Status | Licensed entity | Date | |
|---|---|---|---|---|---|
CYSECTier-2 Cyprus Securities and Exchange Commission | 336/17 | Regulated | Conotoxia Ltd | 2017-09-11 | |
CONSOBTier-1 Commissione Nazionale per le Società e la Borsa | Number pending check | Regulated | CONOTOXIA | 2017-11-15 | |
KNFTier-2 Polish Financial Supervision Authority | Number pending check | Regulated | CONOTOXIA LTD | 2017-11-14 |
Peer regulatory & risk comparison
Side-by-side supervisory and risk benchmark comparing Conotoxia against peer institutions in our institutions licensed across asia-pacific and the middle east dataset.
| Institution | Primary regulators | Regulated / total | Risk classification | Source score | Warnings |
|---|---|---|---|---|---|
| Conotoxia (this record) | CYSECCONSOBKNF | 3 / 3 | Risk level not supplied | — | 0 |
| BAM | FSPRAFSAVARA+12 | 15 / 15 | Risk level not supplied | — | 0 |
| AvaTrade | FSAISAASIC+5 | 8 / 8 | Risk level not supplied | — | 0 |
| Plus500 | FSAASICMAS+3 | 6 / 6 | Risk level not supplied | — | 0 |
| bybit | AFSAFIU-INDVARA+5 | 4 / 8 | Risk level not supplied | — | 0 |
| Saxo | MASASICFSA+5 | 8 / 8 | Risk level not supplied | — | 0 |
Conotoxia: institutional due diligence FAQ
Key supervisory, licensing, and counterparty verification questions generated from the dataset.
What is Conotoxia's regulatory licence status and supervisory authorisation?
In our imported dataset, Conotoxia (legal entity reference: Conotoxia Ltd) holds 3 recorded licence entries, of which 3 carry a "regulated" status and 3 are marked regulated or registered: CYSEC (Cyprus Securities and Exchange Commission) — licence 336/17, status: regulated, Tier-2; CONSOB (Commissione Nazionale per le Società e la Borsa) — licence Number pending check, status: regulated, Tier-1; KNF (Polish Financial Supervision Authority) — licence Number pending check, status: regulated, Tier-2. Institutional due diligence requires verifying that the exact legal entity on your counterparty agreement matches the licensed entity name and registration number on the official CYSEC, CONSOB, KNF public register.
Which of Conotoxia's jurisdictions and licences fall within this site's regulatory coverage?
Conotoxia is registered at Chrysorroiatissi 11, 3032 Limassol, Cyprus. and tracked under our institutions licensed across asia-pacific and the middle east scope based on its institutional service profile (Cryptocurrencies, Precious metals, Indices, Forex, Stocks, Futures, Commodities) rather than a domestic focus licence. Its 3 recorded licences (CYSEC, CONSOB, KNF) should be evaluated for cross-border passporting and local solicitation rules.
What is Conotoxia's institutional risk classification, enforcement exposure, and score profile?
Conotoxia carries a "risk level not supplied" classification in the source dataset (composite numeric scores are not supplied for this record). The record flags 0 regulatory warning or complaint counts. Because these figures reflect imported source fields rather than primary audit findings, compliance teams should review primary enforcement bulletins directly.
What operational due diligence steps apply to Conotoxia's platforms, entity structure, and complaints?
Before allocating capital or executing trades with Conotoxia, institutional and retail allocators should: (1) confirm the domain (forex.conotoxia.com,https//forex.cinkciarz.pl,https://invest.conotoxia.com,https://invest.cinkciarz.pl) against regulator-approved domains to guard against clone firms; (2) verify whether any of the 0 recorded warning/complaint entries or 0 user comments involve withdrawal restrictions or scope violations; and (3) confirm the dispute-resolution ombudsman tied to CYSEC.
Related institutional research & regulatory analysis
Editorial briefings and compliance research from APAC Capital Brief relevant to Conotoxia's supervisory scope.
APAC Semiconductor Capex
India Fully Accessible Route (FAR) Sovereign Bonds in Global Bond Indices: Foreign Institutional Flow Attribution & Balance-Sheet Positioning (10.0% GBI-EM Maximum Index Weight Benchmark)
India Fully Accessible Route (FAR) Sovereign Bonds in Global Bond Indices (INDIA-FAR-BONDS) stands at 10.0% (GBI-EM Maximum Index Weight) (Source: Reserve Bank of India (RBI), 2026-10-20), governing weekly net foreign bu
ASEAN & HKEX Capital Flows
India Fully Accessible Route (FAR) Sovereign Bonds in Global Bond Indices: Return on Equity (ROE) vs. Cost of Equity & Buyback Yield Math (10.0% GBI-EM Maximum Index Weight Benchmark)
India Fully Accessible Route (FAR) Sovereign Bonds in Global Bond Indices (INDIA-FAR-BONDS) stands at 10.0% (GBI-EM Maximum Index Weight) (Source: Reserve Bank of India (RBI), 2026-10-20), governing unwinding strategic c
BOJ & Yen Rates
India Fully Accessible Route (FAR) Sovereign Bonds in Global Bond Indices: Sovereign Yield Curve Repricing & OIS Swap Spreads (10.0% GBI-EM Maximum Index Weight Benchmark)
India Fully Accessible Route (FAR) Sovereign Bonds in Global Bond Indices (INDIA-FAR-BONDS) stands at 10.0% (GBI-EM Maximum Index Weight) (Source: Reserve Bank of India (RBI), 2026-10-20), governing 2s10s and 10s30s curv
TSE Governance & Equities
India Fully Accessible Route (FAR) Sovereign Bonds in Global Bond Indices: Foundry Wafer Capacity, Packaging Bottlenecks & Capex ROI Audit (10.0% GBI-EM Maximum Index Weight Benchmark)
India Fully Accessible Route (FAR) Sovereign Bonds in Global Bond Indices (INDIA-FAR-BONDS) stands at 10.0% (GBI-EM Maximum Index Weight) (Source: Reserve Bank of India (RBI), 2026-10-20), governing CoWoS-L interposer al